US peptide clinic market coverage

Browse city-by-city research pages, provider records, and verification queues for the US peptide, GLP-1, longevity, and telehealth clinic market. This is an editorial directory, not a complete national clinic census or referral pathway.

PeptideUnicorn does not collect intake data, route care, prescribe, dispense, or recommend a clinic.

60

US city market pages

32

States and DC represented

300

City x peptide topic pages

1

Current provider records

How US coverage is prioritised

The directory starts with large US city and metro markets, then layers in regulated GLP-1 demand, longevity clinic density, and editorial verification status. A market page can exist before local clinic records are approved, because the page is also a research checklist for that city.

Population anchors

City and metro coverage is benchmarked against US Census city, town, metro, and micropolitan population estimate releases.

Demand signals

GLP-1 and weight-management context is interpreted alongside CDC adult obesity prevalence data, without making treatment recommendations.

Compliance screen

Records are screened for medical licensing, pharmacy sourcing, prescription pathway clarity, and claims that could conflict with FDA or FTC expectations.

Not exhaustive

The directory does not claim to list every clinic. It separates current records from markets still in the verification queue.

City clinic pages by region

Open provider directory

Northeast

6 markets

South

21 markets

Midwest

12 markets

West

21 markets

Provider records under editorial review

These records are directory content, not recommendations. Readers should verify licensing, prescription requirements, availability, pricing, and pharmacy sourcing directly with the provider.

Authored and reviewed by PeptideUnicorn editorial board. Last reviewed .

Education only, not medical advice. Medical disclaimer